PCSK9

PCSK9 Inhibitors in Practice: Real-World Strategies for Cardiovascular Risk Reduction [Houston]

October 16, 2019

Faculty

Ballantyne

Christie Mitchell Ballantyne, MD
Chief of Cardiology
Baylor College of Medicine
Houston, TX

 

Nambi

Vijay Nambi, MD, PhD
Associate Professor of Medicine
Baylor College of Medicine
Houston, TX

FREE